Multiple sclerosis: First drug to help patients walk now on NHS in England
The NHS in England has approved the drug fampridine to help patients with multiple sclerosis improve their walking ability. The drug, which acts as a signal booster for nerve cells, was previously only available privately or in other parts of the UK.
Why it matters
This decision provides significant relief to MS patients who previously could not afford the high cost of the medication, improving their mobility and independence.
Image source, Aysen Slack Image caption, Aysen Slack says she used to pay for the drug privately until it became too costly
Health and science correspondent Published 23 July 2026, 00:38 BST The first drug to help people with multiple sclerosis walk is being made available on the NHS in England.
Fampridine boosts nerve signals to make it easier for some people to move and live independently.
Aysen Slack, who used to pay for fampridine privately until it became too costly, said the decision would make a "huge difference".
Up to 5,000 people in England could benefit each year. The drug is already available elsewhere in the UK.
Multiple sclerosis is caused by the immune system attacking the protective covering around nerve cells - known as myelin.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in